Figure 2.
Side effects reported at follow-up. (A) Post-treatment pain at follow-up, grouped by timing of follow-up visit. (B) Post-treatment bleeding at follow-up, grouped by timing of follow-up visit. (C) Post-treatment vaginal discharge at follow-up, grouped by timing of follow-up visit. ES, estimate.